))
S1 Ep52: JAK Inhibitor Safety for Treating AD
Manage episode 389992464 series 3538631
Content provided by The Cutaneous Connection. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Cutaneous Connection or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, Christopher Bunick, MD, PhD, associate professor of dermatology at the Yale School Medicine, and a Dermatology Times Editorial Advisory Board member, discusses a paper he recently co-authored, titled “JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies,” with Stefano Daniele, PhD candidate of the Medical Scientist Training Program at the Yale School of Medicine.
71 episodes
Share
